New study tracks lung function and symptoms in fibrosis patients on nintedanib

NCT ID NCT05503030

First seen Nov 01, 2025

Summary

This study looked at 88 adults with connective tissue disease-related lung scarring who were prescribed nintedanib. Researchers measured changes in lung function and tracked cough and breathlessness using a questionnaire over 24 months. The goal was to see if improvements in lung function matched up with fewer symptoms in everyday life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG DISEASES, INTERSTITIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • "ATTIKON" University General Hospital

    Athens, 12462, Greece

  • "G. Gennimatas" General Hospital of Athens

    Athens, 11527, Greece

  • "G. Papanikolaou" General University of Thessaloniki

    Thessaloniki, 57010, Greece

  • "Hippokration" General Hospital of Thessaloniki

    Thessaloniki, 54642, Greece

  • "Ippokration" General Hospital of Athens

    Athens, 11527, Greece

  • "KAT" General Hospital

    Athens, 14561, Greece

  • "Laiko" General Hospital of Athens

    Athens, 11527, Greece

  • Private physician

    Athens, 10676, Greece

  • Private physician

    Athens, 11362, Greece

  • Private physician

    Athens, 11634, Greece

  • Private physician

    Ioannina, 45332, Greece

  • Private physician

    Larissa, 41222, Greece

  • Private physician

    Nea Smirni, Athens, 17121, Greece

  • Private physician

    Pátrai, 26504, Greece

  • Private physician

    Thessaloniki, 54622, Greece

  • University General Hospital of Heraklion

    Heraklion, 71003, Greece

  • University General Hospital of Heraklion

    Heraklion, 71110, Greece

  • University General Hospital of Ioannina

    Ioannina, 45500, Greece

  • University General Hospital of Larisa

    Larissa, 41334, Greece

  • University General Hospital of Patra

    Pátrai, 26504, Greece

Conditions

The condition(s) this trial relates to.

interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.